Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Hyperoxia changes the balance of the thioredoxin/peroxiredoxin system in the neonatal rat brain.

Bendix I, Weichelt U, Strasser K, Serdar M, Endesfelder S, von Haefen C, Heumann R, Ehrkamp A, Felderhoff-Mueser U, Sifringer M.

Brain Res. 2012 Nov 12;1484:68-75. doi: 10.1016/j.brainres.2012.09.024. Epub 2012 Sep 21.

PMID:
23006780
2.

Oxygen toxicity is reduced by acetylcholinesterase inhibition in the developing rat brain.

Sifringer M, Bendix I, von Haefen C, Endesfelder S, Kalb A, Bührer C, Felderhoff-Mueser U, Spies CD.

Dev Neurosci. 2013;35(2-3):255-64. doi: 10.1159/000346723. Epub 2013 Feb 27.

PMID:
23445753
3.

Thioredoxin-1 redox signaling regulates cell survival in response to hyperoxia.

Floen MJ, Forred BJ, Bloom EJ, Vitiello PF.

Free Radic Biol Med. 2014 Oct;75:167-77. doi: 10.1016/j.freeradbiomed.2014.07.023. Epub 2014 Aug 6.

4.

Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases.

Sifringer M, Genz K, Brait D, Brehmer F, Löber R, Weichelt U, Kaindl AM, Gerstner B, Felderhoff-Mueser U.

Dev Neurosci. 2009;31(5):394-402. doi: 10.1159/000232557. Epub 2009 Aug 11.

PMID:
19672068
5.

Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain.

Sifringer M, Brait D, Weichelt U, Zimmerman G, Endesfelder S, Brehmer F, von Haefen C, Friedman A, Soreq H, Bendix I, Gerstner B, Felderhoff-Mueser U.

Brain Behav Immun. 2010 Jul;24(5):792-9. doi: 10.1016/j.bbi.2009.08.010. Epub 2009 Sep 1.

PMID:
19729061
6.

Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system.

Drechsel DA, Patel M.

J Biol Chem. 2010 Sep 3;285(36):27850-8. doi: 10.1074/jbc.M110.101196. Epub 2010 Jun 17.

7.

Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes.

Kaindl AM, Sifringer M, Koppelstaetter A, Genz K, Loeber R, Boerner C, Stuwe J, Klose J, Felderhoff-Mueser U.

Ann Neurol. 2008 Nov;64(5):523-34. doi: 10.1002/ana.21471.

PMID:
19067366
8.

In vivo and in vitro evaluation of the effect of 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate on inflammation-sensitized hyperoxia-induced developing brain injury.

Posod A, Krepp Y, Urbanek M, Stock K, Kiechl-Kohlendorfer U, Griesmaier E.

J Neurosci Res. 2013 Nov;91(11):1463-72. doi: 10.1002/jnr.23271. Epub 2013 Aug 23.

PMID:
24038156
9.

Hyperoxia causes inducible nitric oxide synthase-mediated cellular damage to the immature rat brain.

Hoehn T, Felderhoff-Mueser U, Maschewski K, Stadelmann C, Sifringer M, Bittigau P, Koehne P, Hoppenz M, Obladen M, Bührer C.

Pediatr Res. 2003 Aug;54(2):179-84. Epub 2003 May 21.

PMID:
12761356
10.

Estradiol attenuates hyperoxia-induced cell death in the developing white matter.

Gerstner B, Sifringer M, Dzietko M, Schüller A, Lee J, Simons S, Obladen M, Volpe JJ, Rosenberg PA, Felderhoff-Mueser U.

Ann Neurol. 2007 Jun;61(6):562-73.

PMID:
17427919
11.

Evidence for the formation of a covalent thiosulfinate intermediate with peroxiredoxin in the catalytic mechanism of sulfiredoxin.

Roussel X, Béchade G, Kriznik A, Van Dorsselaer A, Sanglier-Cianferani S, Branlant G, Rahuel-Clermont S.

J Biol Chem. 2008 Aug 15;283(33):22371-82. doi: 10.1074/jbc.M800493200. Epub 2008 Jun 14.

13.

Neuroprotection by Caffeine in Hyperoxia-Induced Neonatal Brain Injury.

Endesfelder S, Weichelt U, Strauß E, Schlör A, Sifringer M, Scheuer T, Bührer C, Schmitz T.

Int J Mol Sci. 2017 Jan 18;18(1). pii: E187. doi: 10.3390/ijms18010187.

14.

A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury.

Dzietko M, Boos V, Sifringer M, Polley O, Gerstner B, Genz K, Endesfelder S, Börner C, Jacotot E, Chauvier D, Obladen M, Bührer C, Felderhoff-Mueser U.

Ann Neurol. 2008 Dec;64(6):664-73. doi: 10.1002/ana.21516.

PMID:
19107989
15.

Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain.

Felderhoff-Mueser U, Sifringer M, Polley O, Dzietko M, Leineweber B, Mahler L, Baier M, Bittigau P, Obladen M, Ikonomidou C, Bührer C.

Ann Neurol. 2005 Jan;57(1):50-9.

PMID:
15622543
16.

Protective effects of peroxiredoxin-1 at the injured blood-brain barrier.

Schreibelt G, van Horssen J, Haseloff RF, Reijerkerk A, van der Pol SM, Nieuwenhuizen O, Krause E, Blasig IE, Dijkstra CD, Ronken E, de Vries HE.

Free Radic Biol Med. 2008 Aug 1;45(3):256-64. doi: 10.1016/j.freeradbiomed.2008.03.024. Epub 2008 Apr 16.

PMID:
18452719
17.

[Relation of insulin-like growth factor binding protein-2 with hyperoxia-induced lung injury in term and premature neonatal rats].

Liu HC, Chang LW, Rong ZH, Zhu HP, Zhang QS, Chen HB, Li WB.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Jun;20(6):331-4. Chinese.

18.

Rat lung peroxiredoxins I and II are differentially regulated during development and by hyperoxia.

Kim HS, Kang SW, Rhee SG, Clerch LB.

Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1212-7.

19.
20.

Mitochondrial peroxiredoxins.

Cao Z, Lindsay JG, Isaacs NW.

Subcell Biochem. 2007;44:295-315. Review.

PMID:
18084900

Supplemental Content

Support Center